Now Enrolling In The Jewel IDE Study

Patients who are at high risk for sudden cardiac
arrest upon discharge from recent cardiac
hospitalization are eligible.

Now Enrolling In The Jewel IDE Study

Patients who are at high risk for sudden cardiac arrest upon discharge from recent cardiac hospitalization are eligible.

The Jewel IDE Study

A Clinical Evaluation of the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) in subjects at high risk for sudden cardiac arrest to demonstrate the safety and clinical effectiveness of the Jewel P-WCD.

Providers

Now recruiting for a national study at selected sites across the US, primarily in the southern, midwest, and northeast states.

Patients

The Jewel detects specific life-threatening heart rhythms and delivers an electrical shock to restore normal heart activity.

This product is not currently available for sale in the U.S.